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Abstract: The analysis of electroencephalograms (EEGs) of patients with Alzheimer’s disease (AD)
could contribute to the diagnosis of this dementia. In this study, a new non-linear signal processing
metric, distance-based Lempel–Ziv complexity (dLZC), is introduced to characterise changes between
pairs of electrodes in EEGs in AD. When complexity in each signal arises from different sub-sequences,
dLZC would be greater than when similar sub-sequences are present in each signal. EEGs from
11 AD patients and 11 age-matched control subjects were analysed. The dLZC values for AD
patients were lower than for control subjects for most electrode pairs, with statistically significant
differences (p < 0.01, Student’s t-test) in 17 electrode pairs in the distant left, local posterior left, and
interhemispheric regions. Maximum diagnostic accuracies with leave-one-out cross-validation were
77.27% for subject-based classification and 78.25% for epoch-based classification. These findings
suggest not only that EEGs from AD patients are less complex than those from controls, but also
that the richness of the information contained in pairs of EEGs from patients is also lower than in
age-matched controls. The analysis of EEGs in AD with dLZC may increase the insight into brain
dysfunction, providing complementary information to that obtained with other complexity and
synchrony methods.
Keywords: Alzheimer’s disease; electroencephalogram; non-linear analysis; Lempel–Ziv complexity;
distance-based Lempel–Ziv complexity
1. Introduction
Alzheimer’s disease (AD) is the most prevalent form of dementia in the world [1,2]. Symptoms
include progressive memory, cognitive, and behavioural changes before death, caused by amyloid
plaques and hyperphosphorated tau in the brain. The cause of AD is currently unknown [3] and many
theories have been suggested. These include the amyloid cascade hypothesis [3,4], which suggests
remaining amyloid β, a protein produced during cell metabolism and then usually further broken
down, initiates AD [5], or that it is a disconnection syndrome [6], which is characterised by the loss of
connections between neurones in cortical areas from plaques and cell death [7]. Whatever the cause, it
is currently understood that the alteration of information creation and transportation in the brain is
what hinders the reaction of an AD patient to surrounding stimuli [8].
The gradual onset of AD and its symptoms is a contributing factor to poor AD diagnosis,
a significant problem [9], and the main contributor to the delay of patient diagnosis of up to
4 years from the symptom onset [10]. AD diagnosis is also hampered by frequent syndromic
overlap [11]. The current clinical diagnosis is based on the National Institute of Neurological and
Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association
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NINCDS-ADRDA criteria [12] and facilitated by medical histories, psychiatric evaluation and tests on
a patient’s memory, reasoning and mental state [13], and involving knowledgeable informants other
than the patient [14].
AD is a cortical dementia, changing the interaction between neurons in the brain and,
as a consequence, the dynamical brain activity. Some of these changes can be captured in
electroencephalogram (EEG) recordings [8]. Given this and the portable, non-invasive, and low
cost clinical factors of the EEG, this type of signal is seen as a useful research tool in AD. Further
research into the ability to measure the impact of AD on the EEG may increase the possibility of clinical
use of the EEG in the diagnosis and monitoring of AD in the future. To this end, research in this area is
focused on the optimal signal processing method for this particular application.
There is ample evidence of EEG changes in AD patients [15]. The major effects of AD on the EEG
that have been observed are slowing, reduction of complexity, and perturbations in EEG synchrony [15].
Slowing of the EEG in AD and Mild Cognitive Impairment (MCI) is associated with an increase of
power in low frequency bands delta (0.5–4 Hz) and theta (4–8 Hz) and a decrease of power in the higher
frequency bands alpha (8–13 Hz) and beta (13–30 Hz) (for a detailed review, please see [15]). Slowing
of the EEG in AD is usually quantified by applying a method based on the Fourier transform, i.e.,
a linear transform. However, as a result of the non-linear nature of the EEG [16], the use of non-linear
analysis methods for the characterisation of this biomedical signal could highlight relevant changes
associated with different diseases that might not be detected with conventional linear methods. The
reduction of irregularity and complexity of EEG signals in AD is the main finding obtained with
non-linear methods [8,15,17]. Last, but not least, EEG signals of patients with AD are generally less
synchronous than those from age-matched control subjects [18]. Several methods have been applied
to characterise the synchrony changes of EEG signals in AD (a detailed review can be found in [15]),
either using local measures (i.e., those establishing relationships between pairs of signals) or global
measures (i.e., methods that can be applied to signals from all EEG channels simultaneously) [18].
In spite of the previous findings, there is room for the introduction of novel methods for the
analysis of EEG signals in AD. A possibility consists in extending the measure of complexity changes
in the EEG with a non-linear method to pairs of signals (bivariate) or more channels recorded
simultaneously (multivariate). Lempel–Ziv complexity (LZC) [19] is a popular non-linear method that
has been used to characterise changes to the complexity of the EEG in AD [20–22]. This univariate
method has been shown to be appropriate for the analysis of non-stationary, short data sets [23,24] and
does not need the application of arbitrary variables [25]. However, in spite of its ability to highlight
changes in complexity in EEG signals, univariate LZC cannot quantify the relationships between the
complexities of pairs of electrodes. This has led to the introduction of extensions of the LZC algorithm
to bivariate and multivariate contexts [25–27].
In this pilot study we introduce a new LZC algorithm based on the concept of distance, the
distance-based LZC (dLZC), to estimate the complexity of pairs of signals. We hypothesised that this
method would highlight regional differences between EEG signals from AD patients and age-matched
control subjects, and that these could be used to classify EEG signals automatically. We also tested the
performance of the method with synthetic data.
The outline of the paper is as follows. Section 2 describes the EEG database and introduces
dLZC and the synthetic data used to test the method. Results with synthetic data and EEG signals are
presented in Section 3, starting with an analysis of the results obtained for different pairs of electrodes
and the classification accuracy that could be achieved with it, prior to presenting regional differences.
The discussion of results and conclusions from this research follow in Section 4.
Entropy 2017, 19, 129 3 of 15
2. Materials and Methods
2.1. Subjects and EEG Recording
Twenty-two subjects, 11 patients with a diagnosis of AD (5 men; 6 women; age: 72.5 ± 8.3 years,
mean ± standard deviation (SD)) and 11 age-matched controls (7 men; 4 women; age: 72.8 ± 6.1 years,
mean ± SD), took part in this pilot study. These subjects were recruited from the Alzheimer’s Patients’
Relatives Association of Valladolid (AFAVA), Valladolid, Spain, and the AD patients fulfilled the criteria
of probable AD. Informed consent was obtained for all 22 subjects and the local ethics committee
approved the study.
The diagnosis of probable AD was supported by clinical evaluation including clinical history,
physical and neurological examination. Brain scans were included, as was a Mini-Mental State
Examination (MMSE) to evaluate the level of dementia impact on each subject. The average MMSE
score for the AD patients was 13.1 ± 5.9 (mean ± SD). All control subjects had an MMSE score of 30.
EEGs were recorded from each subject at the Hospital Clínico Universitario de Valladolid (Spain)
at electrodes F3, F4, F7, F8, Fp1, Fp2, T3, T4, T5, T6, C3, C4, P3, P4, O1, O2, Fz, Cz and Pz of the
international 10–20 system. All electrodes were referenced to the linked ear lobes of each subject.
Recordings were taken in a resting but awake state, with eyes closed. EEG data were recorded for each
subject. EEGs were collected using Profile Study Room 2.3.411 EEG equipment (Oxford Instruments,
Oxford, UK). This applied a low-pass hardware filter of 100 Hz before the signals were sampled at
256 Hz and digitised with a 12-bit A-to-D converter.
Artefact-free sections of the EEG signals were selected by Dr Pedro Espino, the specialist
neurophysiologist overseeing the recording of the EEGs, and were then copied as ASCII files for
analysis offline. Artefacts included movement and noise and in no case electroencephalographic
signs of sleep were observed. These epochs were 5 s (1280 data points) in length. On average,
28.0 ± 15.1 epochs (mean ± SD) were selected from each electrode for each subject. The total number
of artefact-free epochs analysed was 9849, with 5648 epochs corresponding to AD patients and
4201 epochs corresponding to control subjects.
Before non-linear analysis, all EEGs were filtered in both forward and reverse directions to avoid
net phase shift with a Hamming window FIR filter with order 426 and cut-off frequencies at 0.5 Hz
and 40 Hz to remove residual artefacts.
2.2. Synthetic Data
Although modelling a signal as the EEG is difficult as a result of the complex nature of this
biomedical signal, different efforts have been made. Mathematical models of EEG signals are often
represented by a second-order non-linear differential equation; any coupling between two or more
signals is also described by a strength parameter, often in the form of a further differential equation [28].
Therefore, to test the performance of dLZC, two coupled dynamical non-linear systems were
used: a Rössler–Rössler system (no directionality) and a directed Rössler system driving a Lorenz
system, as depicted in [29]. The driver is an autonomous Rössler system with:
.
x1 = −α{x2 + x3}
.
x2 = α{x1 + 0.2x2}
.
x3 = α{0.2 + x3(x1 − 5.7)},
(1)
which drives a Lorenz system with the coupling strength C = 8:
.
y1 = 10{−y1 + y2}
.
y2 = 28y1 − y2 − y1y3 + Cx22
.
y3 = y1y2 −
8
3
y3,
(2)
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These synthetic data, with each oscillator consisting of 5000 data points in length and sampled
at 1000 Hz, were obtained from [30]. Coupling values, α, were investigated from no coupling to full
coupling, 0 to 1, in equal steps of 0.05.
2.3. Distance-Based Lempel–Ziv Complexity
A distance-based measure can be useful to identify the differences seen between pairs of signals.
A true distance measure satisfies three main criteria [26]. If D(x, y) is the distance measure between
signals x and y, these criteria can be identified as:
1. Non-negative, i.e., D(x, y) ≥ 0;
2. Symmetric, i.e., D(x, y) = D(y, x);
3. Satisfy the triangle inequality, i.e., D(x, y) ≤ D(x, z) + D(z, y )
By satisfying these three criteria, a distance-based measure makes no prior assumptions as to
the path the information takes, and thus the location and timing of any signal similarities, around
the brain.
This concept was used in [26] to introduce bivariate distance measures based on LZC. As well as
successfully applying all five measures to construct a phylogenic tree based on mitochondrial DNA
with only one misplacement, four of the five measures were also mathematically proven as distance
measures within an appendix of [26].
However, we previously showed that there were some problems with the normalisation applied
in the distances introduced by Otu and Sayood [26] when using them for the analysis of EEG signals
in AD [31]. Therefore, the introduction of a new distance-based metric based on LZC is needed.
LZC complexity is based on the symbolisation of the original time series. This involves converting
the original time series into a discrete sequence with a finite number of symbols in a coarse-graining
stage. In this pilot study the EEGs were converted into binary sequences using the median as the
threshold Td. In this coarse-graining step, a sequence P = s(1), s(2), . . . , s(n) is created by comparing
the samples from the original sampled signal x(i) with the threshold, with s(i) given by:
s(i) =
{
0 i f x(i) < Td
1 i f x(i) ≥ Td
(3)
To compute the LZC from this binary sequence, P has to be scanned from left to right and a
complexity counter is increased every time a new subsequence is found. A detailed description of the
LZC parsing algorithm can be found in [32].
The aforementioned complexity algorithm would return a complexity value that is dependent
on the length of the sequence being scanned. Therefore, the complexity counter must be normalised
against its upper bound to create comparable results [19]. For a binary sequence of length n, this upper
bound is [33]:
b(n) =
n
log2(n)
(4)
Thus, LZC can be calculated as follows:
C(n) =
c(n)log2(n)
n
(5)
In order to extend the concept of LZC to pairs of signals, we introduce dLZC. If a signal x(n) is
coarse-grained to form a binary sequence P and signal y(n) to form a binary sequence Q, dLZC can be
computed as follows:
dLZC(x, y) =
c(PQ)− c(PP) + c(QP)− c(QQ)
b(2n)
(6)
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where c(PQ) denotes the complexity counter for the concatenation of P and Q, c(QP) denotes
the complexity counter for the concatenation of Q and P, c(PP) is the complexity counter for the
concatenation of P and P, c(QQ) is the complexity counter for the concatenation of Q and Q, and the
normalisation takes into account that the concatenation duplicates the length of the signals.
The dLZC of signal pairs with few sub-sequences in common would be higher than in signal
pairs with a large percentage of sub-sequences in common. Therefore, dLZC measures how
dissimilarly complex two signals might be: dLZC for two complex signals with similar complexity (i.e.,
characterised by a high LZC complexity value but arising from similar sub-sequences) would be lower
than dLZC for two complex signals with their high complexities arising from different sub-sequences.
In order to evaluate the dissimilarity in complexity of EEG signals over local and remote distances,
a subset of pairs of electrodes was chosen. Local pairs focused on the local anterior (Fp1-F7, Fp2-F8,
Fp1-F3, Fp2-F4, Fp1-C3, Fp2-C4, F7-C3, F8-C4, F3-C3 and F4-C4) and the local posterior (O1-P3, O2-P4,
O1-T5, O2-T6, O1-C3, O2-C4, P3-C3, P4-C4, T5-C3 and T6-C4) regions, while distant pairs spanned
the central line (Fp1-O1, Fp2-O2, F7-O1, F8-O2, F3-O1, F4-O2, Fp1-P3, Fp2-P4, F7-P3, F8-P4, F3-P3,
F4-P4, Fp1-T5, Fp2-T6, F7-T5, F8-T6, F3-T5 and F4-T6). The interhemispheric dLZC was also estimated
between all pairs of interhemispheric electrodes. These pairs of electrodes have been previously used
in the non-linear analysis of EEG signals of AD patients [34].
2.4. Statistical Analysis
For the dLZC results from the EEG database, a Lilliefors test was applied to investigate the
distribution of the dLZC results, and a Bartlett or Levene test, chosen upon the results of the Lilliefors
test, was applied to analyse homoscedascity. A Student’s t-test or Kruskal–Wallis tests were also
applied to results to evaluate the statistical significance of differences between individual electrode or
region pairs. In all the above statistical analysis, statistical significance was set at p < 0.01 [35].
Statistically significant electrode pairs were then further analysed using Receiver Operating
Characteristic (ROC) curves and Leave-One-Out (LOO) cross-validation analysis. ROC curves are a
measure for observing the classification performance of a given method and hypothesis. It provides
results of sensitivity, i.e., true positives, specificity, i.e., true negatives, and accuracy, i.e., both true
positives and true negatives [36].
In this pilot study, both subject-based LOO cross-validation and epoch-based LOO cross-validation
were applied. In the first, all results from one subject were removed and the analysis was run on
a dataset of 21 subjects; this was then used to classify the results from the removed subject and
this was compared to the correct result. This was repeated for all subjects. For epoch-based LOO
cross-validation, this method was amended to removing one epoch from one subject at each test.
Therefore, sensitivity would either correspond to the percentage of AD patients or EEG epochs from
AD patients correctly classified, specificity would either correspond to the percentage of control
subjects or EEG epochs from control subjects correctly identified, and accuracy would represent the
percentage of total subjects or EEG epochs correctly identified as corresponding to AD or a control.
Furthermore, dLZC results were grouped into 7 different groups corresponding to right local
anterior, left local anterior, right local posterior, left local posterior, right distant, left distant, and
interhemispheric regions, and a two-way analysis of variance (ANOVA) was chosen to evaluate the
interactions between electrode or region pairs and the diagnostic groups. As a result of the different
number of tests of significance performed, significance was set at p = 0.0071 following a Bonferroni
correction of 7.
3. Results
3.1. dLZC of Synthetic Data
The Rössler–Lorenz coupled system was found to have greater dLZC than the Rössler–Rössler
coupled system for the same coupling in all cases, as shown in Table 1. Furthermore, the range of
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dLZC values was also greater for the latter. As the level of coupling increases, however, there is not a
consitent trend of results for either type of system. Maximum dLZC values were found with 0.7 and
1.0 coupling for the Rössler–Rössler coupled system (no directionality) and 0.45 for the Rössler–Lorenz
system. Minimum dLZC values were found with 0.3 coupling for the Rössler-Rössler coupled system
and 0.05 and 1.0 coupling for the Rössler system driving a Lorenz system.
Table 1. Distance-based Lempel-Ziv Complexity (dLZC) results for differently coupled Rössler–Rössler
and Rössler–Lorenz coupled systems.
Coupling Rössler–Rössler Rössler–Lorenz
0.0 0.2609 0.2786
0.05 0.2388 0.2698
0.1 0.2123 0.3450
0.15 0.2211 0.3317
0.2 0.2167 0.3892
0.25 0.2433 0.3715
0.3 0.1592 0.4157
0.35 0.2344 0.3406
0.4 0.2477 0.3848
0.45 0.2654 0.4467
0.5 0.2521 0.3715
0.55 0.2433 0.4069
0.6 0.2433 0.3317
0.65 0.2344 0.4202
0.7 0.2521 0.4334
0.75 0.2433 0.3450
0.8 0.2211 0.4025
0.85 0.2433 0.3804
0.9 0.2388 0.3052
0.95 0.2433 0.3582
1.0 0.2521 0.2698
3.2. dLZC of EEG Data
To test the stability of dLZC for different signal lengths, an analysis was performed with epoch
sizes ranging from 5 to 2560 data points. Figure 1 shows an example of this. Results suggest that dLZC
values are stable for epoch sizes similar to those used in this study.
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Figure 1. dLZC values for electrode pair P3-O1 for an Alzheimer’s disease (AD) patient with varying
epoch sizes. The vertical line corresponds to the epoch size used in this study (1280 data points).
Next, dLZC was computed for the different aforementioned electrode pairs. Figures 2 and 3
summarise the average dLZC values for all electrode pairs for control subjects and AD patients.
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The dLZC values were consistently higher for controls than for patients, suggesting that electrode
pairs for AD patients are jointly less complex than electrode pairs for age-matched control subjects.
The differences between dLZC values from control subjects and AD patients are particularly evident
for pairs including electrodes from the occipital, parietal, and temporal regions. The dLZC results
were found to be normally distributed and homoscedastic in nature. Statistically significant (p < 0.01,
Student’s t-test) differences were seen in 17 electrode pairs, with the distant electrode pair Fp1-P3 being
the most statistically significant, p = 0.0016, followed by the distant electrode pair Fp1-O1 (p = 0.0026)
and the interhemispheric electrode pair O2-P3 (p = 0.0026).
Figure 4 summarises all electrode pairs for which significant differences between the dLZC values
of AD patients and control subjects were found (p < 0.01, Student’s t-test). It can be seen that these
differences are more pronounced on the left hemisphere, with no significant differences between
electrode pairs for the right local anterior, right local posterior, and right distant electrode pairs.
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Figure 4. Statistically significant (p < 0.01, Student’s t-test) electrode pairs for dLZC.
To ascertain the possible usefulness of dLZC in a diagnostic context, ROC curves with LOO
cross-validation were used for subject-based and epoch-based classification and sensitivity (percentage
of AD patients or AD patients’ EEG epochs correctly classified), specificity (proportion of control
subjects or control subjects’ epochs identified as such by the method), and accuracy (percentage of
total subjects or EEG epochs correctly classified) were computed for all electrode pairs highlighted in
Figure 4. The optimum threshold for the ROC curves was chosen to be that maximising the accuracy
of the classification. The results for subject-based and epoch-based classifications are summarised in
Table 2.
Table 2. Subject-based and epoch-based sensitivity, specificity, and accuracy of the dLZC results for
all the electrode pairs where significant differences between AD patients and control subjects were
found. Results were computed using leave-one-out (LOO) cross-validation. DL: Distant Left; LPL:
Local Posterior Left; I: Interhemispheric.
Region
Electrode
Pair
Subject-Based Epoch-Based
Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy
DL
Fp1-O1 63.64 81.82 72.73 69.97 66.92 68.67
Fp1-P3 63.64 72.73 68.18 62.89 69.58 65.75
Fp1-T5 72.73 63.64 68.18 68.84 67.6 68.34
F3-O1 81.82 72.73 77.27 73.94 63.88 69.64
F3-P3 72.73 72.73 72.73 61.19 72.24 65.91
LPL
O1-P3 72.73 81.82 77.27 75.35 72.24 74.03
O1-T5 72.73 81.82 77.27 81.02 68.82 75.81
I
Fp1-O2 72.73 81.82 77.27 77.05 65.40 72.08
Fp1-P4 63.64 81.82 72.73 62.04 63.12 62.50
Fp1-T6 63.64 90.91 77.27 63.17 68.44 65.42
F3-O2 72.73 63.64 68.18 83.85 59.32 73.38
O1-O2 72.73 63.64 68.18 83.57 71.10 78.25
O1-P4 72.73 81.82 77.27 78.75 69.20 74.68
O1-T6 .64 90.91 77.27 78.47 70.72 75.16
O2-P3 .82 54.5 68.18 78.19 69.96 74.68
O2-T5 81.82 63.64 72.73 75.35 71.10 73.54
P3-P4 54.55 63.64 59.09 67.14 67.30 67.21
i t ac uracy was 77.27% for subject-based classification (a result that w s obtained with
distant left, local posterior left, and in erhemispheric electrode pairs) and 78.25% for epoch-based
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classification (a result obtained with the interhemispheric electrode pair O1-O2). Sensitivity reached
a maximum of 81.82% for subject-based classification (at distant left electrode pair F3-O1 and
interhemispheric pairs O2-P3 and O2-T5) and also exceeded 80% for some electrode pairs in
epoch-based classification (83.57% at interhemispheric pair O1-O2, 83.85% at interhemispheric pair
F3-O2, and 81.02% at local posterior left electrode pair O1-T5). Last, but not least, the maximum
specificity was 90.91% for subject-based classification (obtained at interhemispheric electrode pairs
including the temporal electrode T6: Fp1-T6 and O1-T6), but did not exceed 72.24% for epoch-based
classification (at distant left electrode pair F3-P3 and local posterior left electrode pair O1-P3). These
results suggest that some pairs of electrodes could contribute to an improved sensitivity, whilst others
have to be considered when trying to maximise the specificity of the method.
Finally, to evaluate the significance of the observed regional changes of dLZC, its values were
averaged into seven different regions corresponding to right local anterior, left local anterior, right
local posterior, left local posterior, right distant, left distant, and interhemispheric pairs of electrodes.
Table 3 summarises the results, showing that significant differences (p < 0.0071) were found for the
local posterior left and distant left regions, but not for the rest. This suggests that the averaging of
dLZC values limits the potential identification of differences between groups at some regions, as
Table 2 shows that differences between AD patients and control subjects could be found at some
interhemispheric electrode pairs. ANOVA analysis with the independent variable of diagnosis shows
statistically significant differences for both diagnosis and electrode pairs with no significant interaction
(diagnosis F = 389.38, df = 1, p = 2.00 × 10−80, electrode pairs F = 3.13, df = 119, p = 2.82 × 10−25,
interaction F = 0.6805, df = 119, p = 0.9965). With mean results for region analysis, only diagnosis was
found to be statistically significant (diagnosis F = 38.26, df = 1, p = 6.42 × 10−9, region F = 1.3778, df = 6,
p = 0.2276, interaction F = 0.6229, df = 6, p = 0.7117).
Table 3. The average values and standard deviations of the local, distant, and interhemispheric dLZC
in the AD patients and control subjects. Significant differences are highlighted with an asterisk. LAR:
Local Anterior Right; LAL: Local Anterior Left; LPR: Local Posterior Right; LPL: Local Posterior Left;
DR: Distant Right; DL: Distant Left; I: Interhemispheric.
Mean± SD LAR LAL LPR LPL * DR DL * I
Controls 0.35 ± 0.05 0.36 ± 0.04 0.40 ± 0.05 0.40 ± 0.04 0.37 ± 0.03 0.39 ± 0.04 0.38 ± 0.04
AD patients 0.33 ± 0.05 0.32 ± 0.05 0.34 ± 0.06 0.33 ± 0.07 0.33 ± 0.05 0.32 ± 0.05 0.34 ± 0.05
Table 4 shows the classification results obtained with the averaged dLZC values for those regions
where significant differences were found. It can be seen that accuracies, sensitivities, and specificities
are, in most cases, significantly lower than when considering the electrode pairs separately.
Table 4. Subject-based and epoch-based sensitivity, specificity, and accuracy of the dLZC results
averaged in regions. Only results for regions where significant differences between AD patients and
control subjects were found are shown. Results were computed using LOO cross-validation. LPL: Local
Posterior Left; DL: Distant Left.
Region
Subject-Based Epoch-Based
Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy
LPL 54.55 63.64 59.09 74.22 69.96 72.40
DL 72.73 63.64 68.18 67.42 66.54 67.05
4. Discussion and Conclusions
In this pilot study, a new non-linear signal processing metric, dLZC, was introduced and used
in the characterisation of resting state EEG activity of 11 AD patients and 11 control subjects. This
new metric consists in modifying the well-known LZC algorithm [19] and applying it to pairs of
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signals, and satisfies the criteria for the mathematical definition of distance [26]. In that way, the
method does not reflect any directional trends in the data (i.e., dLZC(x, y) = dLZC(y, x)), but the overall
complexity of pairs of signals. For this reason it is, therefore, particularly appropriate for the analysis
of resting state EEG signals. With dLZC, the concept of algorithmic complexity is extended to pairs of
signals. The dLZC of signal pairs would be higher when complexity in each signal arises from different
sub-sequences than when similar sub-sequences are present in each signal. Therefore, for dLZC to be
high, not only the complexity of each separate signal needs to be high, but their high complexities also
need to be resulting from different sub-sequences in each signal.
The dLZC values for AD patients were lower than for age-matched control subjects for most
electrode pairs, although statistically significant differences were only found in electrode pairs in
the distant left (Fp1-O1, Fp1-P3, Fp1-T5, F3-O1, F3-P3), local posterior left (O1-P3, O1-T5), and
interhemispheric regions (Fp1-O2, Fp1-P4, Fp1-T6, F3-O2, O1-O2, O1-P4, O1-T6, O2-P3, O2-T5, P3-P4).
The range of dLZC values for both subject groups was similar to that corresponding to a Rössler-Lorenz
coupled system, but was higher than for a Rössler-Rössler coupled system, suggesting that a degree of
complex coupling is present in EEG signals.
The possible diagnostic value of dLZC was assessed using ROC curves with LOO cross-validation
in those electrode pairs where dLZC values were significantly different between AD patients and
control subjects. With a subject-based classification scheme, the highest accuracy was 77.27% at
different electrode pairs in the distant left, local posterior left, and interhemispheric regions; accuracy
was slightly better (78.25%) using an epoch-based classification. It is worth noting that the highest
sensitivity values were obtained using an epoch-based classification (83.85% at interhemispheric pair
F3-O2 vs. maximum subject-based classification sensitivities of 81.82% at electrode pairs F3-O1, O2-P3
and O2-T5). On the other hand, specificity was significantly higher for subject-based classification
(90.91% at interhemispheric electrode pairs Fp1-T6 and O1-T6 vs. maximum specificity of 72.24%
for epoch-based classification at electrode pairs F3-P3 and O1-P3). Therefore, electrode pairs need
to be carefully chosen; interhemispheric pairs including T6 might lead to a high specificity but not
necessarily a high sensitivity, which improves when O2 is part of the electrode pair being considered.
It should be noted that dLZC did not highlight any group differences between electrode pairs for the
right local anterior, right local posterior, and right distant electrodes.
To minimise the number of comparisons, dLZC values were averaged in seven different
regions [34] corresponding to right local anterior, left local anterior, right local posterior, left local
posterior, right distant, left distant, and interhemispheric electrode pairs. Classification results were
notably worse using the averaged dLZC values. In particular, the statistically significant differences
for the interhemispheric pairs reported in Table 2 disappeared when combining all electrodes. This
suggests that local measures (i.e., those establishing relationships between pairs of signals) are useful
to highlight differences related to changes to brain activity in AD patients that might not be detected
with a more global, region-based approach.
This same database has been previously analysed with different univariate (i.e., methods analysing
electrodes separately rather than electrode pairs) non-linear methods well-suited to the characterisation
of short and noisy biomedical signals. In particular, a significantly reduced LZC (p < 0.01, Student’s
t-test) was found at electrodes T5, P3, P4 and O1 in AD patients with a 3 symbol coarse-graining and
at P3 and O1 with a 2 symbol coarse-graining similar to that used in this study, with subject-based
classification accuracies—without LOO cross-validation procedure—between 72.73% and 81.82% [20].
These electrodes are among those part of the electrode pairs for which dLZC highlights significant
differences between AD patients and age-matched control subjects. This is in agreement with the
interpretation of this novel metric as a measure of how similarly or dissimilarly complex two signals
might be, with higher dLZC associated with pairs of complex signals with dissimilar complexity.
However, it is worth noting that LZC failed to identify any significant differences between both groups
at Fp1, F3, or T6. On the other hand, significant differences were found between AD patients and
control subjects at electrodes T5, T6, P3, P4, O1 and O2 (p < 0.01, Student’s t-test) using the rate
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of decrease of auto-mutual information (AMI), an information theory method [37]. Subject-based
classification accuracies—without LOO cross-validation procedure—for the rate of decrease of AMI
ranged from 81.82% to 90.91% [37]. This method has been interpreted as a measure of the degree of
complexity in time series [34], so finding significant differences at T6 would be in agreement with the
interpretation of dLZC as a measure of complexity for pairs of signals. Last, but not least, complexity
in this database has also been characterised with multiscale entropy (MSE) [38]. Significant differences
between the MSE of the EEG on large time scales of AD patients and controls (p < 0.01, Student’s
t-test) were found at F3, F7, Fp1, Fp2, T5, T6, P3, P4, O1, and O2, with subject-based classification
accuracies—without LOO cross-validation—between 77.27% and 90.91% [39]. Recently introduced
extensions of MSE also support the notion of decreased complexity in certain areas of the brain in AD
patients with the same database used in this study [40]. Therefore, although a comparison between
univariate methods and dLZC is not straightforward, previous results support the loss of complexity
at some electrodes that are part of the electrode pairs in which significant differences between groups
were found with dLZC. This is also in agreement with the decrease of physiological complexity with
disease [41]. Table 5 summarises the most significant results obtained with this database using other
non-linear methods, such as entropies, like Sample Entropy (SampEn) [42], Approximate Entropy
(ApEn) [37], and MSE [39], metrics correlated with entropy, like the rate of decrease of the AMI [37],
LZC [20], and Detrended Fluctuation Analysis (DFA) [43], a method providing an estimation of scaling
information and long-range correlations in time series. Nevertheless, it should be mentioned that
all these studies did not characterise joint properties of pairs of electrodes, but rather focused on
analysing each electrode separately and that, in most cases, the classification results did not include
LOO or epoch-based classifications and might, therefore, be overestimating the diagnostic accuracies
of univariate methods such as SampEn, ApEn, LZC, MSE, or AMI.
Even though a significant body of work exists measuring the changes in the EEG of AD patients
with local measures (i.e., those measuring some type of relationship between signals recorded at pairs of
electrodes) showing a decrease in synchrony in AD [18], a comparison between studies is not as simple
as a result of the different databases and recording conditions. The most frequently applied linear
measures are magnitude and phase coherences, and decreased coherences in AD and MCI patients
in comparison to controls have often been found (see [15] for a review of some of these studies).
Coherence has been used in conjunction with graph theory as well, achieving a LOO cross-validation
accuracy of 93.8% between AD patients and controls [44]. Recently, the bispectral index was applied to a
16 channel EEG, averaged to five regions. This achieved maximum significance of p = 0.0004 in the two
temporal regions, F7, T3 and T5, and F8, T4 and T6 with the weighted centre, while the central parietal
region, C3, C4, P3 and P4, was found not to be significant [45]. Wavelet coherence has also been used
in the analysis of differences between AD patients and control subjects, with statistically significant
differences found in the 0–4 Hz and 4–8 Hz bands [46]. Increased coherence in intrahemispheric
connections was found with phase lag index (PLI), while interhemispheric connections were increased
in AD patients’ EEGs with phase coherence and decreased with PLI [47].
Information theory methods have also been used to characterise the relationships between
electrode pairs in AD. Reduced cross-mutual information within the EEGs of AD patients has been
identified in the frontal and anterior temporal regions when compared against age-matched control
subjects [34]. Significant decreases of mutual information for AD patients in comparison to controls
have also been found at electrodes Fp1, Fp2, T3 and T4, indicating a lack of information transmission
in these areas [48]. Furthermore, reduced frontal to left temporal and increased left temporal to frontal
and occipital to left central entropies with an accuracy of 93.8% were seen between AD patients and
control subjects with transfer entropy [49], while Sugihara causality analysis achieved an overall
accuracy after a three-way classification of 97.9% [50]. Nevertheless, although it is not straightforward
to compare our results with previous findings, the decrease of dLZC in AD is consistent with reported
losses of average EEG complexity and synchrony in this type of dementia.
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Table 5. Subject-based and epoch-based sensitivity, specificity, and accuracy for all the electrodes
where significant differences between AD patients and control subjects were found with a selection of
other relevant non-linear methods previously used in the analysis of the same electroencephalogram
database. NR: not reported; * denotes the studies in which LOO was used.
Method Electrode
Subject-Based Epoch-Based
Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy
Sample Entropy
(SampEn) (m = 1,
r = 0.25) [42]
P3 72.73 81.82 77.27 NR NR NR
P4 63.64 90.91 77.27 NR NR NR
O1 81.82 72.73 77.27 NR NR NR
O2 90.91 63.64 77.27 NR NR NR
Lempel-Ziv Complexity
(LZC) (3 symbol
conversion) [20]
T5 72.73 72.73 72.73 NR NR NR
P3 81.82 81.82 81.82 NR NR NR
P4 72.73 90.91 81.82 NR NR NR
O1 90.91 72.73 81.82 NR NR NR
Slope of Multiscale
Entropy (MSE) (m = 1,
r = 0.25, 12 scales) for
large time scales [39]
F3 81.82 81.82 81.82 NR NR NR
F7 81.82 72.73 77.27 NR NR NR
Fp1 90.91 90.91 90.91 NR NR NR
Fp2 100 72.73 86.36 NR NR NR
T5 90.91 81.82 86.36 NR NR NR
T6 81.82 81.82 81.82 NR NR NR
P3 81.82 90.91 86.36 NR NR NR
P4 72.73 90.91 81.82 NR NR NR
O1 81.82 90.91 86.36 NR NR NR
O2 81.82 81.82 81.82 NR NR NR
Approximate Entropy
(ApEn) (m = 1,
r = 0.25) [37]
P3 72.73 81.82 77.27 NR NR NR
P4 63.64 81.82 72.73 NR NR NR
O1 81.82 72.73 77.27 NR NR NR
O2 90.91 63.64 77.27 NR NR NR
Auto-Mutual
Information (AMI) rate
of decrease [37]
T5 90.91 72.73 81.82 NR NR NR
T6 81.82 81.82 81.82 NR NR NR
P3 100.00 81.82 90.91 NR NR NR
P4 81.82 81.82 81.82 NR NR NR
O1 81.82 81.82 81.82 NR NR NR
O2 81.82 81.82 81.82 NR NR NR
* Detrended Fluctuation
Analysis (DFA)
(α2) [43]
T5 54.55 81.82 68.18 54.05 85.19 69.10
T6 72.73 72.73 72.73 60.98 79.50 69.91
O1 54.55 72.73 63.64 60.98 81.71 71.07
The possible neurophysiological implications of the reduction of dLZC in the EEG of AD patients
are not completely clear. It has been hypothesised that decreased EEG complexity in AD might be
caused by neuronal death, a general effect of neurotransmitter deficiency, and/or loss of connectivity
of local neural networks as a result of nerve cell death [8]. The decrease of joint complexity in electrode
pairs observed in AD with dLZC is consistent with the view of AD as a disconnection syndrome, where
the loss of afferent and efferent neuron connections destroys effective communication throughout
the brain, thus producing the range of AD symptoms commonly seen [6]. This disconnection could,
therefore, alter the joint complexity of signals recorded simultaneously at different electrodes.
In spite of these promising results, some limitations of our study merit consideration. First of
all, the sample size (11 AD patients and 11 control subjects) is small and leads this to be a pilot study.
Although LOO cross-validation techniques have been used to minimise the bias in the subject-based
and epoch-based classification, and the latter addresses the issue of the small number of subjects by
considering individual epochs rather than subjects in the classification, the sample size might also have
had an impact on the classification results. Therefore, further research is needed with a greater number
of AD patients and controls to assess the possible clinical usefulness of dLZC. Another limitation
arises from the fact that EEG dLZC values might be affected by brain events other than changes of
joint complexity in resting state, by volume conduction (active sources in a particular area of the brain
might affect different electrodes across the scalp), or recording choices like reference electrodes. The
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latter could obviously be mitigated by always using the same reference electrodes and by basing
the analysis on the differences between populations rather than absolute dLZC values. In addition,
the decrease of dLZC observed in the EEG of AD patients might not be exclusive to this pathology.
To ascertain the possible use of the method in the context of AD diagnosis, further studies on patients
with MCI and other forms of dementia than AD are needed. Last, but not least, potential future studies
would include a more in-depth analysis of dLZC in the context of signal processing, a comparison
with other methods measuring dependencies between pairs of signals, and a study on the effects of
volume conduction on dLZC results.
In summary, dLZC was introduced in this study as a measure of the relationships between pairs
of signals and was used in the characterisation of changes in resting state EEG in AD. This novel
metric measures how dissimilarly complex two signals might be: the dLZC value for two signals
with each having a high value of LZC arising from a similar set of sub-sequences would be lower
than that of signals that would have high LZC values but arising from different sets of sub-sequences.
As a result of this, dLZC would allow for capturing subtle differences in complexity between pairs
of time series; this would make it possible to analyse dependencies between pairs of signals in a
novel way, providing information that might not be detected with conventional synchrony metrics.
Results showed that dLZC is consistently higher for controls than for AD patients, suggesting not
only that EEG signals from AD patients are less complex than those from controls, but also that the
richness of the information contained in pairs of EEG signals from patients is also lower than in
age-matched controls. The analysis of EEG signals in AD with dLZC may increase the insight into
brain dysfunction in this dementia and complement the information obtained with other complexity
and synchrony techniques.
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